Phase I trial of R115777 [tipifarnib] (NSA 702818) in advanced malignant solid tumours
Phase of Trial: Phase I
Latest Information Update: 16 Feb 2010
At a glance
- Drugs Tipifarnib (Primary)
- Indications Solid tumours
- Focus Adverse reactions
- 16 Feb 2010 Actual end date (Jul 2008) added as reported by ClinicalTrials.gov.
- 25 Oct 2007 Status changed from in progress to completed.
- 16 Sep 2005 New trial record.